- Corporate Officers - K
- Karabelas Argeris N
Insider Trading History of Karabelas Argeris N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Karabelas Argeris N since 2006.
This trader's CIK number is 1191229.
At the time of last reporting, Karabelas Argeris N was the Officer of Regenxbio Inc.. (stock ticker symbol RGNX).
Also see all insider trading activities at Regenxbio Inc..
Note that in the past
KARABELAS ARGERIS N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biodelivery Sciences International Inc (BDSI) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | BDSI | 0 | $0 | 1,395,000 | $9,335,990 | 0 | $0 |
Yearly summary of insider trading at Regenxbio Inc. (RGNX) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | RGNX | 0 | $0 | 41,100 | $524,119 | 41,100 | $298,665 |
Yearly summary of insider trading at Rocket Pharmaceuticals, Inc. (ITEK) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | ITEK | 603,832 | $3,622,992 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | VNDA | 0 | $0 | 200,000 | $2,360,000 | 0 | $0 |
2009 | VNDA | 0 | $0 | 800,000 | $9,409,058 | 0 | $0 |
2007 | VNDA | 0 | $0 | 893,730 | $23,752,383 | 0 | $0 |
2006 | VNDA | 0 | $0 | 1,720,475 | $33,124,577 | 0 | $0 |
Yearly summary of insider trading at Human Genome Sciences Inc (HGSI) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | HGSI | 12,500 | $151,875 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bausch Health Companies Inc. (VRX) by Karabelas Argeris N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | VRX | 4,000 | $98,600 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Karabelas Argeris N:
1. Biodelivery Sciences International Inc (BDSI)
2. Regenxbio Inc. (RGNX)
3. Rocket Pharmaceuticals, Inc. (ITEK)
4. Vanda Pharmaceuticals Inc. (VNDA)
5. Human Genome Sciences Inc (HGSI)
6. Bausch Health Companies Inc. (VRX)
Table 1. Insider trading of Biodelivery Sciences International Inc (BDSI) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-07-15 | BDSI | Sale | 27,770 | 6.00 | 166,675 |
2009-07-16 | BDSI | Sale | 131,374 | 6.89 | 905,298 |
2009-07-07 | BDSI | Sale | 13,158 | 6.12 | 80,579 |
2009-07-08 | BDSI | Sale | 261 | 6.25 | 1,631 |
2009-07-02 | BDSI | Sale | 6,511 | 6.45 | 42,002 |
2009-07-06 | BDSI | Sale | 70,000 | 6.18 | 432,530 |
2009-07-01 | BDSI | Sale | 50,000 | 6.75 | 337,750 |
2009-06-30 | BDSI | Sale | 32,640 | 6.68 | 217,904 |
2009-06-26 | BDSI | Sale | 477,509 | 6.86 | 3,273,324 |
2009-06-29 | BDSI | Sale | 215,791 | 6.88 | 1,484,210 |
2009-06-25 | BDSI | Sale | 38,965 | 6.51 | 253,506 |
2009-06-24 | BDSI | Sale | 12,559 | 6.48 | 81,419 |
2009-06-22 | BDSI | Sale | 11,657 | 6.56 | 76,434 |
2009-06-23 | BDSI | Sale | 32,800 | 6.30 | 206,771 |
2009-06-19 | BDSI | Sale | 110,614 | 6.54 | 723,526 |
2009-06-17 | BDSI | Sale | 100,000 | 6.40 | 640,200 |
2009-06-18 | BDSI | Sale | 63,391 | 6.50 | 412,231 |
Table 2. Insider trading of Regenxbio Inc. (RGNX) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-10-01 | RGNX | Option Ex | 10,000 | 3.76 | 37,600 |
2024-10-01 | RGNX | Sale | 10,000 | 10.11 | 101,050 |
2024-08-01 | RGNX | Option Ex | 10,100 | 8.25 | 83,325 |
2024-08-01 | RGNX | Sale | 10,100 | 14.35 | 144,884 |
2024-07-29 | RGNX | Sale | 11,000 | 15.04 | 165,495 |
2024-07-29 | RGNX | Option Ex | 11,000 | 12.74 | 140,140 |
2024-07-01 | RGNX | Sale | 10,000 | 11.27 | 112,690 |
2024-07-01 | RGNX | Option Ex | 10,000 | 3.76 | 37,600 |
Table 3. Insider trading of Rocket Pharmaceuticals, Inc. (ITEK) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-02-23 | ITEK | Buy | 603,832 | 6.00 | 3,622,992 |
Table 4. Insider trading of Vanda Pharmaceuticals Inc. (VNDA) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-03-12 | VNDA | Sale | 200,000 | 11.80 | 2,360,000 |
2009-12-15 | VNDA | Sale | 98,924 | 11.03 | 1,091,131 |
2009-12-14 | VNDA | Sale | 130,000 | 11.14 | 1,448,200 |
2009-12-09 | VNDA | Sale | 107,200 | 11.57 | 1,240,304 |
2009-12-08 | VNDA | Sale | 26,376 | 11.30 | 298,048 |
2009-12-04 | VNDA | Sale | 100,000 | 11.70 | 1,170,000 |
2009-12-07 | VNDA | Sale | 100,000 | 11.57 | 1,157,000 |
2009-10-13 | VNDA | Sale | 237,500 | 12.65 | 3,004,375 |
2007-02-23 | VNDA | Sale | 384,130 | 26.02 | 9,993,526 |
2007-02-22 | VNDA | Sale | 72,600 | 26.82 | 1,947,277 |
2007-02-21 | VNDA | Sale | 237,000 | 26.74 | 6,337,380 |
2007-02-20 | VNDA | Sale | 200,000 | 27.37 | 5,474,200 |
2006-12-12 | VNDA | Sale | 424,150 | 25.18 | 10,680,097 |
2006-12-11 | VNDA | Sale | 326,325 | 26.40 | 8,614,980 |
2006-11-27 | VNDA | Sale | 300,000 | 14.18 | 4,254,000 |
2006-11-22 | VNDA | Sale | 300,000 | 14.12 | 4,236,000 |
2006-11-21 | VNDA | Sale | 50,000 | 14.55 | 727,500 |
2006-11-17 | VNDA | Sale | 270,000 | 14.25 | 3,847,500 |
2006-11-20 | VNDA | Sale | 50,000 | 15.29 | 764,500 |
Table 5. Insider trading of Human Genome Sciences Inc (HGSI) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-11-10 | HGSI | Buy | 12,500 | 12.15 | 151,875 |
Table 6. Insider trading of Bausch Health Companies Inc. (VRX) by Karabelas Argeris N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-08-11 | VRX | Buy | 4,000 | 24.65 | 98,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Karabelas Argeris N
(Officer of Regenxbio Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.